Elderly doctor buys clinic building

DOCTOR Mikuláš Čurik from Trstená in north-western Slovakia won a tender to buy the Tehelná walk-in clinic complex in Bratislava with an offer of Sk165 million (€4.34 million).

The starting price set by the National Property Fund (FNM) privatization agency was Sk46 million (€1.21 million).

Čurik's bid beat the offers of capital groups such as Penta and J&T, the daily SME wrote. It is rare that an individual wins such a tender for a medical centre because of the massive initial investments that are required for repairs and development.

The weekly magazine Plus sedem dní reported that the 60-year-old Čurik lives in a modest two-room flat in an older apartment building. He has lived his entire life in Trstená and does not have a computer or even a typewriter in his office.

Given the buyer's apparent lack of surplus funds, speculation has arisen that Čurik is a cover for a capital group. At the moment the doctor is on holiday and has not commented on the transaction.

FNM spokeswoman Tatjana Lesajová said the fund had received confirmation from a bank that Čurik has the money to cover the purchase.

Compiled by Marta Ďurianová from press reports
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.

Get daily Slovak news directly to your inbox

Top stories

From COVID-19 miracle to apparent resignation to death and dying

The natural reflex of all failed politicians – and their uncritical fan clubs – is to point to cultural or geographical differences between “us” and “them”.

The COVID-19 ward in the University Hospital Martin

Developed at home, the production of Slovakia's COVID-19 vaccine will move abroad

Neuroimmunologist Norbert Žilka oversees the development of the ACvac1 vaccine at Axon Neuroscience.

Norbert Žilka is the director of the Institute of Neuroimmunology of the Slovak Academy of Sciences (SAV) and also the scientific director of Axon Neuroscience.